Jenny Levy is a litigation partner who has been with Kirkland & Ellis for 15 years. She has appeared before trial courts and arbitration panels across the country. Jenny focuses on complex commercial litigation, pharmaceutical litigation, and product liability cases. She has litigated a wide variety of cases including consumer protection actions, allegations of fraud and misrepresentation, breach of contract, business torts, product liability, antitrust, false claims qui tam actions, and class actions. Her practice has involved a diverse array of subject matters including Medicaid/Medicare fraud, drug pricing fraud and unfair competition (AWP/WAC inflation), HIPPA and data security, contracts for the sale of energy, contracts for the sale of businesses and stock purchase agreements, alleged violations of shareholder agreements, international licensing agreements, allegations of unlawful insurance practices, allegations of antitrust violations on behalf of drug manufacturers, and numerous product liability cases on behalf of manufacturers of automotive products, lead products, tobacco and pharmaceuticals. Jenny is the pro bono coordinator for Kirkland's Washington, D.C. office.
Lead counsel for Teva Pharmaceuticals and related entities in complex multidistrict commercial litigation involving more than 20 cases brought by state Attorneys General alleging Medicaid/Medicare fraud and unfair competition based on purported inflation of published drug prices (AWP/WAC)
Lead counsel for Teva Pharmaceuticals and related entities in major qui tam False Claims Act litigation alleging drug pricing fraud (AWP/WAC inflation)
Lead counsel for Accretive Health in action brought by Minnesota AG alleging violations of HIPAA and state debt collection laws and related congressional inquiries
Lead counsel for Accretive Health in various arbitrations, lawsuits and investigations pending in multiple jurisdictions
Lead counsel for Baxter International and Teva Pharmaceuticals and related entities in major product liability litigation
Lead counsel for National Lead Company in major lead paint litigation and legislative efforts
Counsel for General Motors in variety of product liability cases and class actions involving automotive components
Counsel for Brown & Williamson in major tobacco product liability litigation
Counsel for ConocoPhillips in arbitration involving the sale of a major convenience store business
Counsel for Cogentrix Energy, Inc. in variety of complex energy litigations involving contracts for the sale of electricity and for the purchase of coal
Counsel for Barr Laboratories in antitrust case involving settlement agreement between a brand and generic drug manufacturers
Counsel for BASF in international arbitration involving licensing agreement for the sale of agricultural products
Counsel for Nationwide Insurance in cases involving allegations of insurance "redlining."
Counsel for Brown & Williamson in product liability litigation against tobacco industry
Counsel for Honeywell in product liability/UCC case involving electronic entry access systems
Counsel for PharmaResearch, Inc. in case involving the breach of a shareholder agreement
Counsel in a matter litigated before state election officials resulting in removal of a candidate from the federal election ballot for fraud
Counsel for numerous pro bono clients in various civil rights, benefits, and other actions against the District of Columbia
Counsel for pro bono client in historic and highly-publicized death penalty case in which the Governor of Virginia commuted client's death sentence
Profiled in The National Law Journal's annual "Champions and Visionaries" feature in July 2012
Recognized in The Legal 500 U.S. for Product Liability and Mass Tort Defense in both Pharmaceuticals and Medical Devices in 2012 as well as for Consumer Products in 2012 and 2013
Listed as a "Washington, D.C. Super Lawyer" by Super Lawyers magazine in 2013
Recognized as one of Fortune Magazine's "Women Leaders in the Law" in 2013
Jenny's representation of Baxter International was featured in "Lawyers: Hepatitis C outbreak doesn't happen if drug makers sell smaller anesthetic vials," from the September 12, 2011 Las Vegas Review-Journal.
Quoted in "Litigation Department of the Year," The American Lawyer, January 2008, as a member of Kirkland's winning Litigation Team for 2007.